Nu Skin Enterprises, Inc.
NUS
$4.79
$0.091.92%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -15.44% | -14.17% | -14.26% | -12.10% | -11.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.44% | -14.17% | -14.26% | -12.10% | -11.79% |
| Cost of Revenue | -14.26% | -12.53% | -11.28% | 4.11% | -7.13% |
| Gross Profit | -15.95% | -14.88% | -15.50% | -17.68% | -13.69% |
| SG&A Expenses | -14.97% | -15.43% | -16.85% | -15.62% | -14.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.74% | -14.50% | -15.11% | -10.11% | -11.97% |
| Operating Income | -26.62% | -8.22% | 1.45% | -33.74% | -8.88% |
| Income Before Tax | -122.46% | 254.50% | 212.08% | 211.38% | 175.49% |
| Income Tax Expenses | 1,039.30% | 421.80% | 226.48% | 324.78% | 331.43% |
| Earnings from Continuing Operations | -314.61% | 241.45% | 209.28% | 206.20% | 167.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -314.61% | 241.45% | 209.28% | 206.20% | 167.92% |
| EBIT | -26.62% | -8.22% | 1.45% | -33.74% | -8.88% |
| EBITDA | -23.29% | -14.56% | -10.19% | -30.07% | -11.02% |
| EPS Basic | -319.79% | 242.44% | 209.55% | 206.29% | 167.96% |
| Normalized Basic EPS | -30.86% | -4.52% | 10.98% | -11.55% | 2.82% |
| EPS Diluted | -323.21% | 235.83% | 208.05% | 204.71% | 167.13% |
| Normalized Diluted EPS | -31.52% | -5.30% | 9.93% | -12.24% | 2.76% |
| Average Basic Shares Outstanding | -1.94% | -1.63% | -0.74% | -0.01% | 0.06% |
| Average Diluted Shares Outstanding | -0.52% | -0.16% | 0.69% | 0.71% | 0.36% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | -57.89% | -73.33% |
| Payout Ratio | -1.46% | 1.69% | 1.91% | 1.40% | 1.39% |